Cover Image
市場調查報告書

青光眼:全球臨床實驗檢討

Glaucoma Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 240562
出版日期 內容資訊 英文 105 Pages
訂單完成後即時交付
價格
Back to Top
青光眼:全球臨床實驗檢討 Glaucoma Global Clinical Trials Review, H1, 2015
出版日期: 2015年06月11日 內容資訊: 英文 105 Pages
簡介

本報告提供全球青光眼治療藥物臨床實驗相關調查,不同地區的臨床實驗數資料,實驗階段,實驗狀況,採用主題及各類型贊助企業的臨床實驗資料,中斷(暫時停止,廢止,停止)的實驗清單等資料,為您概述為以下內容。

目錄

  • 表格一覽
  • 圖表一覽
  • 簡介
  • 青光眼
  • 報告指南
  • 臨床實驗 , 各地區
  • 臨床實驗 , 各國
  • - 亞太地區對臨床實驗有所貢獻的主要5個國家
  • - 歐洲對臨床實驗有所貢獻的主要5個國家
  • 對臨床實驗有所貢獻的主要國家 - 北美
  • - 中東及非洲對臨床實驗有所貢獻的主要5個國家
  • - 中南美對臨床實驗有所貢獻的主要5個國家
  • 臨床實驗 金磚四國 各國
  • 臨床實驗 G7 各國
  • 臨床實驗 - G7 各國 , 各臨床實驗狀態
  • 臨床實驗 E7 各國
  • 臨床實驗 - E7 各國 , 各臨床實驗狀態
  • 各階段臨床實驗
  • 進行中的臨床實驗 各階段
  • 臨床實驗 , 各臨床實驗狀態
  • 未完成的臨床實驗; 青光眼
  • 每段時期的實驗人數
  • 有力的贊助商
  • 參加主要企業 - 青光眼 治療藥物的臨床實驗
  • 潛力治療藥物比較
  • 臨床實驗簡介
  • 臨床實驗概要; 主要企業
  • Allergan, Inc.
  • 臨床實驗概要; Allergan, Inc.
  • Pfizer Inc.
  • 臨床實驗概要; Pfizer Inc.
  • Alcon, Inc.
  • 臨床實驗概要; Alcon, Inc.
  • Alcon Research Ltd.
  • 臨床實驗概要; Alcon Research Ltd.
  • QLT Inc.
  • 臨床實驗概要; QLT Inc.
  • 參天製藥
  • 臨床實驗概要; 參天製藥
  • Merck & Co., Inc.
  • 臨床實驗概要; Merck & Co., Inc.
  • GLAUKOS Corporation
  • 臨床實驗概要; GLAUKOS Corporation
  • Aerie Pharmaceuticals, Inc.
  • 臨床實驗概要; Aerie Pharmaceuticals, Inc.
  • Pro Top and Mediking Co., Ltd.
  • 臨床實驗概要; Pro Top and Mediking Co., Ltd.
  • 興和
  • 臨床實驗概要; 興和
  • Pharmaceutical Research Network LLC
  • 臨床實驗概要; Pharmaceutical Research Network LLC
  • Laboratorios Sophia S.A. de C.V.
  • 臨床實驗概要; Laboratorios Sophia S.A. de C.V.
  • Santen Oy
  • 臨床實驗概要; Santen Oy
  • Sensimed AG
  • 臨床實驗概要; Sensimed AG
  • Bausch & Lomb Incorporated
  • 臨床實驗概要; Bausch & Lomb Incorporated
  • Sun Pharma Advanced Research Company
  • 臨床實驗概要; Sun Pharma Advanced Research Company
  • LABORATOIRES THEA
  • 臨床實驗概要; LABORATOIRES THEA
  • Transcend Services, Inc.
  • 臨床實驗概要; Transcend Services, Inc.
  • VISTAKON Pharmaceuticals, LLC
  • 臨床實驗概要; VISTAKON Pharmaceuticals, LLC
  • 臨床實驗概要; 最高級大學 / 研究機關 / 醫院
  • Wills Eye Institute
  • 臨床實驗概要; Wills Eye Institute
  • Medical University of Vienna
  • 臨床實驗概要; Medical University of Vienna
  • Aristotle University of Thessaloniki
  • 臨床實驗概要; Aristotle University of Thessaloniki
  • University Hospital Basel
  • 臨床實驗概要; University Hospital Basel
  • Yonsei University
  • 臨床實驗概要; Yonsei University
  • Beijing Tongren Hospital
  • 臨床實驗概要; Beijing Tongren Hospital
  • Singapore National Eye Centre
  • 臨床實驗概要; Singapore National Eye Centre
  • 廣島大學醫院
  • 臨床實驗概要; 廣島大學醫院
  • University of Colorado
  • 臨床實驗概要; University of Colorado
  • Federal University of Sao Paulo
  • 臨床實驗概要; Federal University of Sao Paulo
  • Shaheed Beheshti Medical University
  • 臨床實驗概要; Shaheed Beheshti Medical University
  • 熊本大學
  • 臨床實驗概要; 熊本大學
  • Hong Kong Eye Hospital
  • 臨床實驗概要; Hong Kong Eye Hospital
  • Johns Hopkins University
  • 臨床實驗概要; Johns Hopkins University
  • University Health Network
  • 臨床實驗概要; University Health Network
  • Dresden University of Technology
  • 臨床實驗概要; Dresden University of Technology
  • University of Zurich
  • 臨床實驗概要; University of Zurich
  • National University Hospital
  • 臨床實驗概要; National University Hospital
  • University of Nebraska
  • 臨床實驗概要; University of Nebraska
  • University of Parma
  • 臨床實驗概要; University of Parma
  • Five 主要 臨床簡介

附錄

  • 簡稱
  • 定義
  • 調查方法
  • 二級研究
  • About GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

表格一覽

表格一覽

  • 青光眼 治療藥物市場, 全球市場、 臨床實驗 各地區
  • 青光眼 治療藥物市場, 全球市場、 臨床實驗 , 各國排名
  • 青光眼 治療藥物市場, 全球市場、 進行中的臨床實驗 , 各國排名
  • 青光眼 治療藥物的臨床實驗, 亞太地區, 主要5個國家
  • 青光眼 治療藥物的臨床實驗, 歐洲, 主要5個國家
  • 青光眼 治療藥物的臨床實驗, 北美, 主要國家
  • 青光眼 治療藥物的臨床實驗, 中東及非洲, 主要5個國家
  • 青光眼 治療藥物的臨床實驗, 中南美, 主要5個國家
  • 青光眼 治療藥物的臨床實驗, 金磚四國 各國
  • 青光眼 治療藥物的臨床實驗, G7 各國
  • 青光眼 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
  • 青光眼 治療藥物的臨床實驗, E7 各國
  • 青光眼 治療藥物市場, E7 各國, 臨床實驗 , 各臨床實驗狀態
  • 青光眼 治療藥物市場, 全球市場、 各階段臨床實驗
  • 青光眼 治療藥物市場, 全球市場、 進行中的臨床實驗 各階段
  • 青光眼 治療藥物市場, 全球市場、 臨床實驗 , 各臨床實驗狀態
  • 青光眼 治療藥物市場, 全球市場、 暫時停止的臨床實驗
  • 青光眼 治療藥物市場, 全球市場、 中止的臨床實驗
  • 青光眼 治療藥物市場, 全球市場、 終止的臨床實驗
  • 青光眼 治療藥物的臨床實驗, 全球市場、 平均登計對象人數趨勢
  • 青光眼 治療藥物的臨床實驗, 全球市場、 主要的贊助商
  • 青光眼 治療藥物的臨床實驗, 全球市場、 主要企業 各階段
  • 青光眼 治療藥物的臨床實驗, 全球市場、 臨床實驗, 各有潛力治療藥
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Allergan, Inc.
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Pfizer Inc.
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Alcon, Inc.
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Alcon Research Ltd.
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- QLT Inc.
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- 參天製藥
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Merck & Co., Inc.
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- GLAUKOS Corporation
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Aerie Pharmaceuticals, Inc.
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Pro Top and Mediking Co., Ltd.
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- 興和
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Pharmaceutical Research Network LLC
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Laboratorios Sophia S.A. de C.V.
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Santen Oy
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Sensimed AG
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Bausch & Lomb Incorporated
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Sun Pharma Advanced Research Company
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- LABORATOIRES THEA
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Transcend Services, Inc.
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- VISTAKON Pharmaceuticals, LLC
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Wills Eye Institute
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Medical University of Vienna
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Aristotle University of Thessaloniki
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- University Hospital Basel
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Yonsei University
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Beijing Tongren Hospital
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Singapore National Eye Centre
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- 廣島大學醫院
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- University of Colorado
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Federal University of Sao Paulo
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Shaheed Beheshti Medical University
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- 熊本大學
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Hong Kong Eye Hospital
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Johns Hopkins University
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- University Health Network
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Dresden University of Technology
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- University of Zurich
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- National University Hospital
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- University of Nebraska
  • 青光眼 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- University of Parma

圖表一覽

圖表一覽

  • 青光眼 治療藥物市場, 全球市場、 臨床實驗 各地區 (%)
  • 青光眼 治療藥物市場, 全球市場、 臨床實驗 , 各國排名
  • 青光眼 治療藥物市場, 全球市場、 進行中的臨床實驗 , 各國排名
  • 青光眼 (%)治療藥物的臨床實驗, 亞太地區, 主要5個國家
  • 青光眼 (%)治療藥物的臨床實驗, 歐洲, 主要5個國家
  • 青光眼 治療藥物的臨床實驗, 北美, 主要國家 (%)
  • 青光眼 (%)治療藥物的臨床實驗, 中東及非洲, 主要5個國家
  • 青光眼 (%)治療藥物的臨床實驗, 中南美, 主要5個國家
  • 青光眼 治療藥物的臨床實驗, 金磚四國 各國 (%)
  • 青光眼 治療藥物的臨床實驗, G7 各國 (%)
  • 青光眼 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
  • 青光眼 治療藥物的臨床實驗, E7 各國 (%)
  • 青光眼 治療藥物市場, E7 各國, 臨床實驗 , 各臨床實驗狀態
  • 青光眼 治療藥物市場, 全球市場、 各階段臨床實驗 (%)
  • 青光眼 治療藥物市場, 全球市場、 進行中的臨床實驗 各階段
  • 青光眼 治療藥物市場, 全球市場、 臨床實驗 , 各臨床實驗狀態
  • 青光眼 治療藥物的臨床實驗, 全球市場、 平均登計對象人數趨勢
  • 青光眼 治療藥物的臨床實驗, 全球市場、 主要的贊助商
  • 青光眼 治療藥物的臨床實驗, 全球市場、 主要企業 各階段
  • 青光眼 治療藥物的臨床實驗, 全球市場、 臨床實驗, 各有潛力治療藥
  • GlobalData 調查方法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2708CTIDB

GlobalData's clinical trial report, "Glaucoma Global Clinical Trials Review, H1, 2015" provides an overview of Glaucoma clinical trials scenario. This report provides top line data relating to the clinical trials on Glaucoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Glaucoma
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Glaucoma to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Glaucoma to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Glaucoma
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Glaucoma Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Glaucoma
      • May 11, 2015: Isarna Presents Positive Preclinical Results Supporting Development of ISTH0036 for the Treatment of Glaucoma
      • May 11, 2015: Promising preclinical data on NCX 667 for glaucoma presented at ARVO by Nicox
      • May 11, 2015: Promising preclinical data on NCX 470 for glaucoma presented at ARVO by Nicox
      • Apr 28, 2015: Avalanche Biotechnologies to Present at Upcoming Scientific Meetings
      • Apr 16, 2015: Isarna Initiates First-in-Human Phase I Trial for ISTH0036 to Treat Advanced Glaucoma
      • Mar 24, 2015: Aerie Pharmaceuticals Completes Enrollment in Second Phase 3 Registration Trial of Rhopressa, Novel Triple-Action Product to Lower Intraocular Pressure in Patients with Glaucoma
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Actavis plc
      • Clinical Trial Overview of Actavis plc
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Santen Pharmaceutical Co., Ltd.
      • Clinical Trial Overview of Santen Pharmaceutical Co., Ltd.
      • Aerie Pharmaceuticals, Inc.
      • Clinical Trial Overview of Aerie Pharmaceuticals, Inc.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Valeant Pharmaceuticals International, Inc.
      • Clinical Trial Overview of Valeant Pharmaceuticals International, Inc.
      • QLT Inc.
      • Clinical Trial Overview of QLT Inc.
      • Kowa Company, Ltd.
      • Clinical Trial Overview of Kowa Company, Ltd.
      • Mati Therapeutics Inc.
      • Clinical Trial Overview of Mati Therapeutics Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Aristotle University Of Thessaloniki
      • Clinical Trial Overview of Aristotle University Of Thessaloniki
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Beijing Tongren Hospital
      • Clinical Trial Overview of Beijing Tongren Hospital
      • Shahid Beheshti University of Medical Sciences
      • Clinical Trial Overview of Shahid Beheshti University of Medical Sciences
      • Moorfields Eye Hospital NHS Foundation Trust
      • Clinical Trial Overview of Moorfields Eye Hospital NHS Foundation Trust
      • Federal University of Sao Paulo
      • Clinical Trial Overview of Federal University of Sao Paulo
      • Kumamoto University
      • Clinical Trial Overview of Kumamoto University
      • University of Colorado Denver
      • Clinical Trial Overview of University of Colorado Denver
      • Wills Eye Institute
      • Clinical Trial Overview of Wills Eye Institute
      • Chinese University of Hong Kong
      • Clinical Trial Overview of Chinese University of Hong Kong
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Glaucoma Therapeutics, Global, Clinical Trials by Region, 2015*
  • Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Glaucoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Glaucoma Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Glaucoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Glaucoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Glaucoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Glaucoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Glaucoma Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Glaucoma Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Glaucoma Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Glaucoma Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015*
  • Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen Pharmaceutical Co., Ltd., 2015*
  • Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Aerie Pharmaceuticals, Inc., 2015*
  • Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015*
  • Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015*
  • Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by QLT Inc., 2015*
  • Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa Company, Ltd., 2015*
  • Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mati Therapeutics Inc., 2015*
  • Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Aristotle University Of Thessaloniki, 2015*
  • Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015*
  • Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing Tongren Hospital, 2015*
  • Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University of Medical Sciences, 2015*
  • Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Moorfields Eye Hospital NHS Foundation Trust, 2015*
  • Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015*
  • Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kumamoto University, 2015*
  • Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado Denver, 2015*
  • Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Wills Eye Institute, 2015*
  • Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015*

List of Figures

  • Glaucoma Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Glaucoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Glaucoma Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Glaucoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Glaucoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Glaucoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Glaucoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Glaucoma Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top